
Sign up to save your podcasts
Or


Before we talk about December 31st, the FDA, or compounded weight-loss medications, this episode starts with something most people misunderstand:
What compounding pharmacies are actually for.
Joanne begins by explaining the original and ongoing role of compounding pharmacies — using hormone replacement therapy (HRT) as a clear, long-standing example — before addressing why compounded GLP-1 medications existed temporarily and why that chapter is now closing.
This context matters, because without it, everything happening right now sounds dramatic when it really isn’t.
Why compounding pharmacies exist in the first place
How compounding is meant to customize medication, not replace FDA-approved drugs
A clear explanation of compounded HRT, including:
Doses that do not exist in FDA-approved products
Patients who need amounts between standard commercial doses
Delivery methods or formulations that FDA products don’t offer
Why testosterone for women is commonly compounded
Why compounded HRT continues to be appropriate and legal:
Why compounded GLP-1 medications were legally allowed during shortages
How compounding pharmacies were permitted to fill a supply gap, not a medical customization gap
Why this was always intended to be temporary
The difference between individualized medical compounding and mass-market convenience compounding
What actually changed when GLP-1 shortages ended
Why compounding pharmacies were given a wind-down period
Why December 31st became a common operational cutoff
Why this is not a ban, crackdown, or conspiracy — but a return to standard FDA rules
Why compounding still exists — but within narrow, patient-specific boundaries
Why GLP-1 mass compounding no longer fits the legal definition once supply stabilized
How fear-based “stock up now” messaging misses the point
Why medication can be a tool — but not a substitute for education, physiology, and behavior
Joanne also shares her recent reaction to a change in her thyroid medication, using it as a real-world example of why individualized dosing matters — and why nuance in medicine is often lost in online conversations.
All program dates for 2026 are now set.
View the full schedule here:
If you’d like to book a private consultation regarding peptide use, you can contact Joanne directly:
📧 www.5dayshred.com
A foundational program covering body composition, decision-making, and long-term success.
These programs give you a clear feel for how Joanne coaches before stepping into more advanced or longer-term work.
This episode isn’t about losing access — it’s about understanding how compounding was meant to work, why GLP-1 compounding filled a temporary gap, and why returning to clear boundaries actually protects patients.
Clarity beats panic.
By joanne lee cornishBefore we talk about December 31st, the FDA, or compounded weight-loss medications, this episode starts with something most people misunderstand:
What compounding pharmacies are actually for.
Joanne begins by explaining the original and ongoing role of compounding pharmacies — using hormone replacement therapy (HRT) as a clear, long-standing example — before addressing why compounded GLP-1 medications existed temporarily and why that chapter is now closing.
This context matters, because without it, everything happening right now sounds dramatic when it really isn’t.
Why compounding pharmacies exist in the first place
How compounding is meant to customize medication, not replace FDA-approved drugs
A clear explanation of compounded HRT, including:
Doses that do not exist in FDA-approved products
Patients who need amounts between standard commercial doses
Delivery methods or formulations that FDA products don’t offer
Why testosterone for women is commonly compounded
Why compounded HRT continues to be appropriate and legal:
Why compounded GLP-1 medications were legally allowed during shortages
How compounding pharmacies were permitted to fill a supply gap, not a medical customization gap
Why this was always intended to be temporary
The difference between individualized medical compounding and mass-market convenience compounding
What actually changed when GLP-1 shortages ended
Why compounding pharmacies were given a wind-down period
Why December 31st became a common operational cutoff
Why this is not a ban, crackdown, or conspiracy — but a return to standard FDA rules
Why compounding still exists — but within narrow, patient-specific boundaries
Why GLP-1 mass compounding no longer fits the legal definition once supply stabilized
How fear-based “stock up now” messaging misses the point
Why medication can be a tool — but not a substitute for education, physiology, and behavior
Joanne also shares her recent reaction to a change in her thyroid medication, using it as a real-world example of why individualized dosing matters — and why nuance in medicine is often lost in online conversations.
All program dates for 2026 are now set.
View the full schedule here:
If you’d like to book a private consultation regarding peptide use, you can contact Joanne directly:
📧 www.5dayshred.com
A foundational program covering body composition, decision-making, and long-term success.
These programs give you a clear feel for how Joanne coaches before stepping into more advanced or longer-term work.
This episode isn’t about losing access — it’s about understanding how compounding was meant to work, why GLP-1 compounding filled a temporary gap, and why returning to clear boundaries actually protects patients.
Clarity beats panic.